Dupont Capital Management Corp Ironwood Pharmaceuticals Inc Transaction History

Dupont Capital Management Corp

  • $1.18 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Jan 28, 2021
SELL
$9.05 - $12.2 $222,892 - $300,473
-24,629 Closed
0 $0
Q3 2020

Oct 29, 2020
SELL
$8.99 - $10.74 $188,349 - $225,013
-20,951 Reduced 45.97%
24,629 $222,000
Q2 2020

Jul 24, 2020
SELL
$9.14 - $11.97 $228,445 - $299,178
-24,994 Reduced 35.42%
45,580 $470,000
Q4 2019

Jan 27, 2020
BUY
$8.22 - $14.0 $580,118 - $988,036
70,574 New
70,574 $939,000

Others Institutions Holding IRWD

# of Institutions
236
Shares Held
162M
Call Options Held
11.2M
Put Options Held
9.1K
View Full List

About IRONWOOD PHARMACEUTICALS INC

IRWD Quotes by TradingView
  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $607M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Dupont Capital Management Corp Portfolio

Follow Dupont Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Dupont Capital Management Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email